AQR Capital Management - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,526,686
+191.9%
74,183
+566.8%
0.00%
+200.0%
Q2 2023$523,098
-7.6%
11,125
-17.5%
0.00%0.0%
Q1 2023$566,124
-3.7%
13,492
-12.4%
0.00%0.0%
Q4 2022$587,661
-22.6%
15,408
-20.5%
0.00%
-50.0%
Q3 2022$759,000
-58.6%
19,370
-66.4%
0.00%
-50.0%
Q2 2022$1,832,000
-83.3%
57,723
-82.6%
0.00%
-81.0%
Q1 2022$10,981,000
-44.8%
331,746
-29.0%
0.02%
-41.7%
Q4 2021$19,882,000
-15.5%
467,367
-12.4%
0.04%
-18.2%
Q3 2021$23,520,000
+149.2%
533,700
+221.2%
0.04%
+175.0%
Q2 2021$9,440,000
+1085.9%
166,171
+1461.6%
0.02%
+1500.0%
Q1 2021$796,000
+159.3%
10,641
+199.7%
0.00%0.0%
Q4 2020$307,000
-20.7%
3,550
+28.7%
0.00%
Q3 2019$387,000
-22.1%
2,758
+0.3%
0.00%
-100.0%
Q2 2019$497,000
+2.9%
2,749
-9.5%
0.00%0.0%
Q1 2019$483,000
-50.6%
3,037
-70.3%
0.00%0.0%
Q4 2018$978,000
-36.0%
10,209
-5.6%
0.00%0.0%
Q3 2018$1,527,000
-75.1%
10,814
-72.4%
0.00%
-83.3%
Q2 2018$6,131,000
-57.6%
39,171
-56.3%
0.01%
-62.5%
Q1 2018$14,453,000
+82.8%
89,731
+86.9%
0.02%
+100.0%
Q4 2017$7,908,000
+530.1%
48,010
+138.3%
0.01%
+700.0%
Q3 2017$1,255,000
+28.3%
20,148
+64.0%
0.00%0.0%
Q2 2017$978,000
-16.4%
12,286
-25.4%
0.00%
-50.0%
Q1 2017$1,170,000
+479.2%
16,460
+161.0%
0.00%
Q1 2016$202,000
-70.6%
6,306
-46.5%
0.00%
-100.0%
Q4 2015$688,000
-5.2%
11,794
-31.3%
0.00%0.0%
Q3 2015$726,00017,1630.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders